Clinical Trial Update: A Study of CRD3874-SI in People With Solid Tumors [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for CRD3874-SI in people with solid tumors. The study is currently recruiting and targets sarcoma and Merkel cell carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma
• Sarcoma

Drugs mentioned

• CRD3874-SI

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Sarcoma, Merkel Cell Carcinoma | Phase 1 | Status: RECRUITING